European survey of the level of satisfaction of patients and physicians in the management of epilepsy in general practice

Epilepsy & Behavior : E&B
John RossJosemir W Sander

Abstract

Many people with epilepsy report treatment-emergent adverse effects (AEs) while on drug therapy despite optimized treatment. We explored the level of treatment satisfaction with current management among people with epilepsy and treating physicians from seven different European countries. There was discordance between patients and physicians: patients would like greater involvement in discussions regarding treatment options and, although generally satisfied with their current medication, saw the need for a more effective balance between seizure control and AEs. Conversely, physicians were less satisfied with current treatments, but were less concerned with AEs. People with epilepsy also wanted to be better educated about epilepsy and its management. Key challenges for the future include improvement in the self-management of epilepsy by patients and more proactive patient-physician interactions. An additional aim is to improve the public's perception of epilepsy so as to remove any associated stigma.

References

Mar 1, 1997·Epilepsia·G A BakerD Monnet
Apr 4, 2006·Lancet·John S DuncanMatthew C Walker
Apr 17, 2007·Lancet Neurology·Dominic C Heaney, Josemir W Sander
Oct 12, 2007·Neurology·M J V PughL Kazis
Oct 30, 2008·Child and Adolescent Psychiatry and Mental Health·David CoghillJan Buitelaar
Nov 1, 2008·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Nancy F BandstraPeter R Camfield
May 29, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M MulaF Monaco
Oct 27, 2009·Neurologic Clinics·Ann JacobyGus A Baker
Dec 2, 2009·Current Neuropharmacology·Erik K St LouisThomas Bramley

❮ Previous
Next ❯

Citations

Dec 22, 2015·Epilepsy & Behavior : E&B·Louise BennettJohn S G Wells
Apr 12, 2015·Epilepsy & Behavior : E&B·W O PickrellP E M Smith
May 18, 2011·Epilepsy & Behavior : E&B·Waleed M SweilehDonald E Morisky
Nov 1, 2012·Acta Neurologica Scandinavica. Supplementum·M P Kerr
Jan 1, 2015·Epilepsy & Behavior : E&B·Arnaud Biraben, Bashar Allaf
Apr 15, 2016·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Heather May MorganIan S Watt
Dec 3, 2011·Epilepsy & Behavior : E&B·Mary FitzsimonsNorman Delanty

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.